TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announces the closing of its strategic investment in PAD Aviation, a premier Germany-based private aviation operator. Founded in 2006, PAD Aviation is a leading European business aviation operator, independent of commercial airlines. The company operates from its 24/7 hub in Paderborn, Germany, offering maximum flexibility—particularly for time-critical missions such as organ transport.
Read the full article: TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH //
Source: https://www.prnewswire.com/news-releases/transmedics-group-announces-completion-of-strategic-investment-in-pad-aviation-service-gmbh-302818049.html